日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Association Between Epstein-Barr Virus Infection and PD-L1 Expression in Gastric Cancer: Prevalence, Clinicopathological Features, and Prognostic Implications

Epstein-Barr病毒感染与胃癌中PD-L1表达的相关性：患病率、临床病理特征和预后意义

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17091492
Wonglhow, Jirapat; Tantipisit, Jarukit; Wetwittayakhlang, Panu; Sunpaweravong, Patrapim; Sathitruangsak, Chirawadee; Kanjanapradit, Kanet; Thongwatchara, Phatcharaporn; Dechaphunkul, Arunee
胃癌
肿瘤
肿瘤免疫
炎症/感染
微生物学
PD-L1
发表日期：2025
文献求助 收藏

Durvalumab following definitive chemoradiotherapy among patients with stage III NSCLC in the Thai population: a real-world, multicenter observational study

在泰国人群中，接受根治性放化疗后使用度伐利尤单抗治疗III期非小细胞肺癌患者：一项真实世界多中心观察性研究

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1647385
Sitthideatphaiboon, Piyada; Reungwetwattana, Thanyanan; Jaruhathai, Sureerat; Supavavej, Archara; Limpawittayakul, Piyarat; Maneenil, Kunlatida; Korphaisarn, Krittiya; Suksombooncharoen, Thatthan; Thongthieang, Luangyot; Sathitruangsak, Chirawadee; Chayangsu, Chawalit; Ratanabunjerdkul, Hataiwan; Prasongsook, Naiyarat; Sriuranpong, Virote
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Overall survival with frontline vs subsequent anti-epidermal growth factor receptor therapies in unresectable, RAS/BRAF wild-type, left-sided metastatic colorectal cancer

不可切除的RAS/BRAF野生型左侧转移性结直肠癌患者接受一线抗表皮生长因子受体（EGFR）治疗与后续EGFR治疗的总生存期比较

期刊:World Journal of Clinical Oncology
影响因子:3.2
doi:10.5306/wjco.v16.i3.102076
Pakvisal, Nussara; Goldberg, Richard M; Sathitruangsak, Chirawadee; Silaphong, Witthaya; Faengmon, Satawat; Teeyapun, Nattaya; Teerapakpinyo, Chinachote; Tanasanvimon, Suebpong
肿瘤
肠癌
肿瘤免疫
信号转导
EGF
BRAF
EGFR
RAS
发表日期：2025
文献求助 收藏

Role of Adjuvant Chemotherapy in Resected Small Bowel Adenocarcinoma: An Exploratory Real-World Analysis of Survival Outcomes and Prognostic Factors

辅助化疗在切除小肠腺癌中的作用：生存结果和预后因素的探索性真实世界分析

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14217513
Wonglhow, Jirapat; Sunpaweravong, Patrapim; Sathitruangsak, Chirawadee; Dechaphunkul, Arunee; Wetwittayakhlang, Panu
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

A 20-Year Real-World Study of Small Bowel Cancers: Histologic Subtypes, Clinical Features, and Survival Implications

一项为期 20 年的小肠癌真实世界研究：组织学亚型、临床特征和生存意义

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14196962
Wonglhow, Jirapat; Sunpaweravong, Patrapim; Sathitruangsak, Chirawadee; Dechaphunkul, Arunee; Wetwittayakhlang, Panu
肿瘤
肠癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Trends in Cancer Diagnoses Among People Living with HIV: A 20-Year Retrospective Study from a Tertiary Center in Thailand

泰国一家三级医疗中心20年回顾性研究：艾滋病毒感染者癌症诊断趋势

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm15010022
Wonglhow, Jirapat; Chaiwiriyawong, Supakorn; Sunpaweravong, Patrapim; Sathitruangsak, Chirawadee; Dechaphunkul, Arunee
肿瘤
肿瘤免疫
HIV
炎症/感染
微生物学
发表日期：2025
文献求助 收藏

Effectiveness of Palliative Chemotherapy and Associated Prognostic Factors in Advanced Small Bowel Adenocarcinoma: A Propensity Score-Matched Analysis

姑息性化疗对晚期小肠腺癌疗效及相关预后因素的影响：倾向评分匹配分析

期刊:Cancer Management and Research
影响因子:2.6
doi:10.2147/CMAR.S558642
Wonglhow, Jirapat; Dechaphunkul, Arunee; Sathitruangsak, Chirawadee; Sunpaweravong, Patrapim; Wetwittayakhlang, Panu
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

LABS score- a prognostic tool for FOLFOX4-treated advanced hepatocellular carcinoma and real-world efficacy: a single-center retrospective study

LABS评分——FOLFOX4治疗晚期肝细胞癌的预后工具及其真实世界疗效：一项单中心回顾性研究

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-024-12040-z
Wonglhow, Jirapat; Sunpaweravong, Patrapim; Sathitruangsak, Chirawadee; Dechaphunkul, Arunee
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Impact of Clinical Characteristics and Treatment on Cholangiocarcinoma Prognosis in Southern Thailand

临床特征和治疗对泰国南部胆管癌预后的影响

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.70491
Sathitruangsak, Chirawadee; Pattarapuntakul, Tanawat; Kaewdech, Apichat; Thongkan, Tortrakoon; Prisutkul, Apinya; Thongwatchara, Phatcharaporn; Sriplung, Hutcha; Kongkamol, Chanon; Kanokwiroon, Kanyanatt; Obchoei, Sumalee; Sripongpun, Pimsiri
肿瘤
胆管癌
肿瘤免疫
发表日期：2024
文献求助 收藏

The Performance of a Survival Nomogram and Albumin-Bilirubin Grade as Prognostic Tools in Advanced Hepatocellular Carcinoma Treated with FOLFOX4

FOLFOX4方案治疗晚期肝细胞癌患者中，生存列线图和白蛋白-胆红素分级作为预后工具的性能

期刊:Journal of Personalized Medicine
影响因子:3
doi:10.3390/jpm14040403
Wonglhow, Jirapat; Sunpaweravong, Patrapim; Sathitruangsak, Chirawadee; Dechaphunkul, Arunee
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏